Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
United StatesIPO:
01 October 2021Website:
http://www.nutriband.comNext earnings report:
13 December 2024Last dividends:
N/ANext dividends:
N/APrice
regular market | Thu, 14 Nov 2024 14:30:00 GMTDividend
Analysts recommendations
Institutional Ownership
NTRB Latest News
ORLANDO, FL / ACCESSWIRE / September 16, 2024 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), has announced a share repurchase program to buy back up to $1,000,000 of its common stock. As of September 16, 2024, the Company had 11,106,185 shares of common stock outstanding.
ORLANDO, FL / ACCESSWIRE / September 4, 2024 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW) has reported its financial results for the second quarter ended July 31, 2024. The Company reported a strong cash position at quarter end, reinforcing its ability to advance the development of its lead product, AVERSA™ Fentanyl, with an NDA submission targeted for the first half of 2025.
ORLANDO, FL / ACCESSWIRE / July 19, 2024 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a developer of transdermal pharmaceutical solutions, is pleased to invite investors to a webinar on July 25, 2024, at 4:15 p.m. ET. The exclusive event, hosted by RedChip Companies, will feature Nutriband Chairman and President Serguei Melnik and Chief Executive Officer Gareth Sheridan, who will share insight into the Company's current operations and upcoming milestones.
The Glinka family contributed $4.5 million to Nutriband during the Company's private placement in April 2024. Nutriband Inc. appointed Sergei Glinka to its board of directors, a well-respected business executive with extensive experience in leadership roles at prominent European companies.
What type of business is Nutriband?
Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. It also develops AVERSA buprenorphine and AVERSA methylphenidate, and other transdermal pharmaceutical products. The company was incorporated in 2016 and is headquartered in Orlando, Florida.
What sector is Nutriband in?
Nutriband is in the Healthcare sector
What industry is Nutriband in?
Nutriband is in the Biotechnology industry
What country is Nutriband from?
Nutriband is headquartered in United States
When did Nutriband go public?
Nutriband initial public offering (IPO) was on 01 October 2021
What is Nutriband website?
https://www.nutriband.com
Is Nutriband in the S&P 500?
No, Nutriband is not included in the S&P 500 index
Is Nutriband in the NASDAQ 100?
No, Nutriband is not included in the NASDAQ 100 index
Is Nutriband in the Dow Jones?
No, Nutriband is not included in the Dow Jones index
When was Nutriband the previous earnings report?
No data
When does Nutriband earnings report?
The next expected earnings date for Nutriband is 13 December 2024